Skip to main content

HANTZ FINANCIAL SERVICES, INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1071061 SOUTHFIELD, MI

Position in NBIX

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$451,999
-$23,698 QoQ
Shares Held
3,431
+2.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HANTZ FINANCIAL SERVICES, INC. holds $24,766,683 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NBIX
Neurocrine Biosciences Inc
This page
3,431 $451,999

All Filings in NBIX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $451,999 3,431
2025-12-31 $475,697 3,354
2025-09-30 $281,461 2,005
2025-06-30 $164,905 1,312
2025-03-31 $69,567 629
2024-12-31 $92,547 678
2024-09-30 $106,808 927
2024-06-30 $127,620 927
2024-03-31 $129,920 942
2023-12-31 $141,510 1,074
2023-09-30 $132,300 1,176
2023-06-30 $141,167 1,497
2023-03-31 $10,908,783 107,773
2022-12-31 $13,111,645 109,776
2022-09-30 $16,628,131 156,559
2022-06-30 $15,124,996 155,160
2022-03-31 $14,169,187 151,138
2021-12-31 $5,252,944 61,676
2021-09-30 $5,375,084 56,043
2021-06-30 $4,721,674 48,517
2021-03-31 $4,561,219 46,902
2020-12-31 $4,389,930 45,800
2020-09-30 $4,122,379 42,870